Journal of the Pakistan Medical Association (Oct 2022)

The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis

  • Kashaf Waqar,
  • Anika Zainab

DOI
https://doi.org/10.47391/JPMA.6388
Journal volume & issue
Vol. 72, no. 11

Abstract

Read online

Not required